1Department of Anesthesiology and Critical Care, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Department of Cellular and Molecular Nutrition, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3Department of Nutrition and Food Science, California State University, Chico, CA, USA
Copyright © 2021 The Korean Society of Critical Care Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST No potential conflict of interest relevant to this article was reported.
AUTHOR CONTRIBUTIONS
Conceptualization: SHA, GE. Data curation: SHA. Formal analysis: SHA, GE. Funding acquisition: SHA, GE. Methodology: all authors. Project administration: GE. Visualization: SM. Writing–original draft: all authors. Writing–review & editing: SHA, SM.
Variable | Overall (n=162) |
OPNI class |
||
---|---|---|---|---|
Low (≤40, n=102) | High (>40, (n=60) | P-value | ||
Age (yr) | 65 (49–75) | 69.5 (51–79) | 58 (49–70) | 0.002a,b |
Sex | 0.088a,c | |||
Male | 87 (53.7) | 60 (59) | 27 (45) | |
Female | 75 (46.3) | 42 (41) | 33 (55) | |
Hospital to ICU admission (day) | 0.5 (0–1) | 0 (0–1) | 1 (0–1) | 0.242b |
Admission category | 0.021a,c | |||
Medical | 78 (48) | 42 (41) | 36 (60) | |
Surgical | 84 (52) | 60 (59) | 24 (40) | |
Number of comorbidities | 0 (0–2) | 1 (0–2) | 0 (0–1) | 0.043a,b |
Mechanical ventilation | 34 (21) | 20 (20) | 14 (23) | 0.574c |
APACHE II score | 26 (21–36) | 25 (20–35) | 28 (21–40) | 0.066b |
SOFA score | 8 (7–11) | 8 (7-11) | 9 (6-11) | 0.519b |
OPNI score | 32.2 (24.5–45.3) | 27.5 (21.3–31.8) | 46.9 (43.9–51.5) | <0.001a,b |
Total lymphocyte count | 1,513 (890–2,386) | 1,163 (688–1,546) | 2,533 (2,024–2,899) | <0.001a,b |
Serum albumin (g/dl) | 2.5 (2–3.4) | 2 (1.7–2.4) | 3.5 (3.3–3.9) | <0.001a,b |
Serum IL-6 (pg/ml) | 222 (77–454) | 318 (96–477) | 157 (43–422) | <0.001a,b |
Serum hs-CRP | 4.01 (2.98–4.52) | 4.28 (3.77–4.60) | 2.30 (1.56–3.58) | 0.006a,b |
Plasma zonulin (ng/ml) | 6.8 (4.3–11.5) | 8.2 (5.0–12.1) | 6.0 (3.5–9.5) | 0.022a,b |
Plasma endotoxin (EU/mL) | 0.57 (0.33–0.86) | 0.66 (0.40–0.88) | 0.48 (0.31–0.78) | 0.034a,b |
Values are presented as median (interquartile range) or number (%).
OPNI: Onodera’s prognostic nutritional index; ICU: intensive care unit; APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; IL-6: interleukin-6; hs-CRP: high-sensitivity C-reactive protein.
aP<0.05, statistically significant;
bMann-Whitney test;
cChi-square test.
Variable |
Overall (n=162) |
Admission category |
||||
---|---|---|---|---|---|---|
Medical (n=78) |
Surgical (n=84) |
|||||
OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-valuea | |
Plasma zonulin | ||||||
First model | 0.75 (0.69–0.89) | 0.023 | 0.79 (0.75–0.98) | 0.049 | 0.71 (0.60–0.80) | 0.015 |
Second modelb | 0.83 (0.75–0.98) | 0.048 | 0.91 (0.89–1.21) | 0.114 | 0.81 (0.78–0.96) | 0.044 |
Plasma endotoxin | ||||||
First model | 0.73 (0.69–0.81) | 0.021 | 0.80 (0.71–0.90) | 0.032 | 0.73 (0.69–0.89) | 0.032 |
Second modelb | 0.81 (0.72–0.93) | 0.039 | 0.84 (0.80–1.09) | 0.069 | 0.79 (0.75–0.89) | 0.043 |
Serum IL-6 | ||||||
First model | 0.80 (0.70–0.90) | 0.039 | 0.91 (0.88–1.11) | 0.192 | 0.76 (0.75–0.80) | 0.034 |
Second modelb | 0.88 (0.64–0.96) | 0.042 | 0.92 (0.82–1.23) | 0.236 | 0.80 (0.60–0.88) | 0.038 |
Serum hs-CRP | ||||||
First model | 0.74 (0.60–0.86) | 0.031 | 0.78 (0.58–0.88) | 0.040 | 0.65 (0.47–0.73) | 0.012 |
Second modelb | 0.77 (0.53–0.92) | 0.025 | 0.79 (0.59–0.98) | 0.048 | 0.68 (0.52–0.77) | 0.014 |
Variable | Overall (n=162) | OPNI class |
||
---|---|---|---|---|
Low (≤40, n=102) | High (>40, (n=60) | P-value | ||
Age (yr) | 65 (49–75) | 69.5 (51–79) | 58 (49–70) | 0.002 |
Sex | 0.088 |
|||
Male | 87 (53.7) | 60 (59) | 27 (45) | |
Female | 75 (46.3) | 42 (41) | 33 (55) | |
Hospital to ICU admission (day) | 0.5 (0–1) | 0 (0–1) | 1 (0–1) | 0.242 |
Admission category | 0.021 |
|||
Medical | 78 (48) | 42 (41) | 36 (60) | |
Surgical | 84 (52) | 60 (59) | 24 (40) | |
Number of comorbidities | 0 (0–2) | 1 (0–2) | 0 (0–1) | 0.043 |
Mechanical ventilation | 34 (21) | 20 (20) | 14 (23) | 0.574 |
APACHE II score | 26 (21–36) | 25 (20–35) | 28 (21–40) | 0.066 |
SOFA score | 8 (7–11) | 8 (7-11) | 9 (6-11) | 0.519 |
OPNI score | 32.2 (24.5–45.3) | 27.5 (21.3–31.8) | 46.9 (43.9–51.5) | <0.001 |
Total lymphocyte count | 1,513 (890–2,386) | 1,163 (688–1,546) | 2,533 (2,024–2,899) | <0.001 |
Serum albumin (g/dl) | 2.5 (2–3.4) | 2 (1.7–2.4) | 3.5 (3.3–3.9) | <0.001 |
Serum IL-6 (pg/ml) | 222 (77–454) | 318 (96–477) | 157 (43–422) | <0.001 |
Serum hs-CRP | 4.01 (2.98–4.52) | 4.28 (3.77–4.60) | 2.30 (1.56–3.58) | 0.006 |
Plasma zonulin (ng/ml) | 6.8 (4.3–11.5) | 8.2 (5.0–12.1) | 6.0 (3.5–9.5) | 0.022 |
Plasma endotoxin (EU/mL) | 0.57 (0.33–0.86) | 0.66 (0.40–0.88) | 0.48 (0.31–0.78) | 0.034 |
Variable | Overall (n=162) |
Admission category |
||||
---|---|---|---|---|---|---|
Medical (n=78) |
Surgical (n=84) |
|||||
OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value |
|
Plasma zonulin | ||||||
First model | 0.75 (0.69–0.89) | 0.023 | 0.79 (0.75–0.98) | 0.049 | 0.71 (0.60–0.80) | 0.015 |
Second model |
0.83 (0.75–0.98) | 0.048 | 0.91 (0.89–1.21) | 0.114 | 0.81 (0.78–0.96) | 0.044 |
Plasma endotoxin | ||||||
First model | 0.73 (0.69–0.81) | 0.021 | 0.80 (0.71–0.90) | 0.032 | 0.73 (0.69–0.89) | 0.032 |
Second model |
0.81 (0.72–0.93) | 0.039 | 0.84 (0.80–1.09) | 0.069 | 0.79 (0.75–0.89) | 0.043 |
Serum IL-6 | ||||||
First model | 0.80 (0.70–0.90) | 0.039 | 0.91 (0.88–1.11) | 0.192 | 0.76 (0.75–0.80) | 0.034 |
Second model |
0.88 (0.64–0.96) | 0.042 | 0.92 (0.82–1.23) | 0.236 | 0.80 (0.60–0.88) | 0.038 |
Serum hs-CRP | ||||||
First model | 0.74 (0.60–0.86) | 0.031 | 0.78 (0.58–0.88) | 0.040 | 0.65 (0.47–0.73) | 0.012 |
Second model |
0.77 (0.53–0.92) | 0.025 | 0.79 (0.59–0.98) | 0.048 | 0.68 (0.52–0.77) | 0.014 |
Values are presented as median (interquartile range) or number (%). OPNI: Onodera’s prognostic nutritional index; ICU: intensive care unit; APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; IL-6: interleukin-6; hs-CRP: high-sensitivity C-reactive protein. P<0.05, statistically significant; Mann-Whitney test; Chi-square test.
OPNI: Onodera’s prognostic nutritional index; OR: odds ratio; CI: confidence interval. P<0.05; Adjusted for age and Acute Physiology and Chronic Health Evaluation (APACHE) II score.